IH
REGN icon

IFC Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

IFC Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-510
Closed -$227K – 531
2017
Q3 		$227K Buy
510
+30
+6% +$14.3K 0.02% 450
2017
Q2 		$237K Sell
480
-70
-13% -$30.6K 0.02% 424
2017
Q1 		$217K Buy
+550
New +$204K 0.02% 418
2016
Q1 		– Sell
-1,575
Closed -$857K – 405
2015
Q4 		$857K Buy
+1,575
New +$853K 0.11% 134

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

IFC Holdings's REGN Position: Q4 2017 in Review

IFC Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 510 shares — an estimated $227K sold.

IFC Holdings first reported a position in REGN in Q4 2015 and held it in 4 quarters. The position peaked at $857K in Q4 2015. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • IFC Holdings reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • IFC Holdings sold 510 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $227K.
  • IFC Holdings first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • IFC Holdings's Regeneron Pharmaceuticals position peaked at $857K in Q4 2015.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on IFC Holdings's 13F filing for Q4 2017, filed 31 Jan 2018.